Latest Blogs

Mar 24, 2017
When everyone around you is telling you that you are overworked and on the verge of burnout, it's time to listen, reflect, and take action for your own well-being.
Mar 23, 2017
We may never be able to completely eliminate anxiety and stress before and after scans, yet we can definitely make a difference by confronting scanxiety upfront.
Mar 20, 2017
When the basics of cancer control are not in place, should we discuss targeted agents and immunotherapy in resource-constrained settings?
Mar 16, 2017
ASCO soundly opposes President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health.
Subscribe to this column

Don S. Dizon, MD, FACP

Don S. Dizon, MD, FACP, is an Associate Professor at Harvard Medical School and is Clinical Co-Director of Gynecologic Oncology at the Massachusetts General Hospital (MGH) Cancer Center, where he also is Founder and Director of the Oncology Sexual Health Clinic. Dr. Dizon serves as Chair for ASCO's Social Media Working Group and is Immediate Past Chair of the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for MGH and a Section Editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the Journal of Clinical Oncology Editorial Board, and Editor in Chief of the ASCO Educational Book. Follow Dr. Dizon on Twitter @drdonsdizon.

Nov 20, 2014
Even after so many years, I take the process of starting someone on anticancer treatment very seriously. The drugs we use can cause damage, and that damage can persist long after the end of the last planned treatment. Platinum salts can cause neuro- and nephrotoxicity. Taxanes can cause neuropathy...
Nov 06, 2014
In July 1991, I was beginning my first year of medical school in Rochester, New York. I was filled with excitement and anxiety on beginning a journey in medicine as I started on the road to becoming a doctor.
Oct 23, 2014
I remember when I first started in oncology; I had joined the faculty at Brown three years after fellowship and was seeing a patient* with newly diagnosed breast cancer. She was in her 40s, an advertising executive, married, with two small kids. The diagnosis was unexpected (as it usually is), with...
Oct 09, 2014
Whenever I speak about social media, much of it has to do with Twitter. It has become part of my daily routine, much like checking email or going to news media sites. I will often “check-in” on Twitter and will respond to items of interest—whether or not tweets were sent directly to me. However, I...
Sep 26, 2014
I had taken care of her for years. We had faced a new diagnosis, the toxicities of adjuvant treatment, the promises of having no evidence of disease (NED as my friend, Molly refers to it), only to have it shattered with the first recurrence. Over the next three years, she had undergone treatment—...
Sep 11, 2014
I sometimes wonder what I would do if I was told I had cancer. How much would I subject myself to in order to survive, or to achieve remission? As a parent, I can answer only that I would likely go through hell and back if it meant being there for my kids—to watch them grow up, graduate high school...

Pages